Update on Power 3 Medical Products (PWRM) Print E-mail
By Leonard H. Berner   
Wednesday, 25 November 2009 03:00
Many investors have been asking why PWRM did not announce news from the conference in China last week. Did they leave us holding the bag?

As we reported last Wednesday, Dr. Ira Goldknopf, the Chief Scientific Officer of Power 3 Medical Products (PWRM), was scheduled to present a keynote address & chair a session on "Biomarkers & Diagnosticsin Personalized Medicine" at the BIT Life Sciences 2nd International Congress Expo of Molecular Diagnostics in Beijing, China.
We spoke yesterday afternoon with Kenneth Bosket, the very kind gentleman who handles investors relations at PWRM. He informed me that Dr. Goldknopf has just returned from China and that he would be emailing him the full text of his speech today for dissemination.

In addition, Bosket said he will be sending a copy of the text directly to us upon his receipt.

Helen Park, the CEO of PWRM, had told BioMedReports' M.E. Garza last week, that Goddknopf would be reporting "new information" on the results of their recently completed Phase I Clinical Trials for Alzheimer's & Parkinson's diseases blood diagnostic tests which had shown better than expected results.  Shares ran up substantitally upon the news, but no press release was issued by the company after the presentation.

We will let you know all the details as soon as we receive them. Mr. Bosket said the company hopes to release the text to us by Friday, and we will share that with you as soon as we receive it.


We welcome Leonard H. Berner as a new reporter/analyst for BioMedReports. Mr. Berner has been a long time trader/investor in the sector and his solid fundamental analysis skills and hard hitting questions will no doubt win readers of our portal over in the coming months.

"Featured Content" profiles are meant to provide awareness of these companies to investors in the small-cap and growth equity community and should not in any way come across as a recommendation to buy, sell or hold these securities. BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and firms. Full disclosures should be read in the 'About Us Section'.

Add this page to your favorite Social Bookmarking websites
Digg! Reddit! Del.icio.us! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!

blog comments powered by Disqus